1.
Mahale VG, Deshmukh AS, Mahajan VR. Formulation and
Characterization of Inclusion Complexes : A Review. 2014;3(3):476–80.
2.
Kreider GN. A Literary Endorser. J Am Med Assoc.
1897;XXIX(2):90.
3.
Stegemann S, Leveiller F, Franchi D, de Jong H,
Lindén H. When poor solubility becomes an issue: From early stage to proof of
concept. Eur J Pharm Sci. 2007 Aug;31(5):249–61.
4.
Savjani KT, Gajjar AK, Savjani JK. Drug solubility:
importance and enhancement techniques. ISRN Pharm. 2012 Jul;2012:1–10.
5.
Sivakumar M, Tang SY, Tan KW. Cavitation technology
– A greener processing technique for the generation of pharmaceutical
nanoemulsions. Ultrason Sonochem. 2014 Nov;21(6):2069–83.
6.
Morales JO, Watts AB, McConville JT. Mechanical
particle-size reduction techniques. AAPS Adv Pharm Sci Ser. 2016
Dec;22:165–213.
7.
Merisko-Liversidge E, Liversidge GG, Cooper ER.
Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J
Pharm Sci. 2003 Feb;18(2):113–20.
8.
Recharla N, Riaz M, Ko S, Park S. Novel
technologies to enhance solubility of foodderived bioactive compounds : A
review. J Funct Foods [Internet]. 2017;39:63–73. Available from: https://doi.org/10.1016/j.jff.2017.10.001
9.
Habib, M.J., Pharmaceutical solid dispersion
Technology, Technomic Publishing Company, Inc. Lancaster, Pennsylvania
(U.S.A.). 2001, pp. 1-36.
10.
Agarwal A, Singh BK, Trivedi N, Jha KK. Approaches
for enhancement of solubility to improve the absorption and bioavailability of
poorly soluble drugs. Russ J Biopharm. 2015;7(2):3–8.
11.
Leuenberger H, Lanz M. Pharmaceutical powder
technology — from art to science:
the
challenge of the FDA’s Process Analytical Technology initiative. Adv Powder
Technol. 2005 Jan;16(1):3–25.
12.
Davé RN, Bilgili E, Cuitino A, Jallo L. Special
issue on pharmaceutical powders: Towards developing understanding of the
influence of materials and processes on product performance. Powder Technol.
2013 Feb;236:1–4.
13.
Dressman JB, Vertzoni M, Goumas K, Reppas C.
Estimating drug solubility in the gastrointestinal tract. Adv Drug Deliv Rev.
2007 Jul;59(7):591–602.
14.
Khadka P, Ro J, Kim H, Kim I, Tae J, Kim H, et al.
ScienceDirect Pharmaceutical particle technologies : An approach to improve
drug solubility , dissolution and bioavailability. Asian J Pharm Sci
[Internet]. 2014;9(6):304–16. Available from:
http://dx.doi.org/10.1016/j.ajps.2014.05.005
15.
Soliman OAE, Kimura K, Hirayama F, Uekama K,
El-Sabbagh HM, El-Gawad AEGHA, et al. Amorphous
spironolactone-hydroxypropylated cyclodextrin complexes with superior
dissolution and oral bioavailability. Int J Pharm. 1997 Apr;149(1):73–83.
16.
Rao VM, Stella VJ. When can cyclodextrins be
considered for solubilization purposes? J Pharm Sci. 2003
May;92(5):927–32.
17.
Tinwalla AY, Hoesterey BL, Xiang T xiang, Lim K,
Anderson BD. Solubilization of thiazolobenzimidazole using a combination of pH
adjustment and complexation with 2-hydroxypropyl-beta-cyclodextrin. Pharm Res.
1993;10(8):1136–43.
18.
Szejtli J. Medicinal applications of cyclodextrins.
Med Res Rev. 1994;14(3):353–86.
19.
Tetsumi I, Yoshinobu T, Kaneto U, Pitha J. Effect
of bile on the intestinal absorption of α-cyclodextrin in rats. Int J Pharm.
1988 Apr;43(1–2):41–4.
20.
Hirayama F, Uekama K. Cyclodextrin-based controlled
drug release system. Adv Drug Deliv Rev. 1999 Mar;36(1):125–41.
21.
Loftsson T, Brewster ME. Pharmaceutical
applications of cyclodextrins. 1. Drug solubilization and stabilization. J
Pharm Sci. 1996;85(10):1017–25.
22.
Stella VJ, Rao VM, Zannou EA, Zia V. Mechanisms of
drug release from cyclodextrin complexes. Adv Drug Deliv Rev. 1999
Mar;36(1):3–16.
23.
Carrier RL, Miller LA, Ahmed I. The utility of
cyclodextrins for enhancing oral bioavailability. 2007;123:78–99.
24.
Article R. an overview on solubility enhancement
techniques for poorly soluble drugs and solid. 2012;3(04):942–56.
25.
Arun K, Babu CJ, Laksmaiah P, Rao CB, Ravi B,
Harshavardhan P. Techniques to Improve the Absorption of Poorly Soluble Drugs
of Solubility. Int J Res Pharm Chem. 2012;2(2):533–40.
26.
Chaudhary VB, Pharmacy SS. Chaudhary & Patel,.
Cyclodext Incl Complex To Enhanc Solubility Poorly Water Soluble Drugs a Rev.
2013;4(1):68–76.
27.
Sanghvi R, Evans D, Yalkowsky SH. Stacking
complexation by nicotinamide: a useful way of enhancing drug solubility. Int J
Pharm. 2007 May;336(1):35–41.
28.
Higuchi T, Kristiansen H. Binding specificity
between small organic solutes in aqueous solution: classification of some
solutes into two groups according to binding tendencies. J Pharm Sci.
1970;59(11):1601–8.
29.
Rajewski RA, Stella VJ. Pharmaceutical applications
of cyclodextrins. 2. In vivo drug delivery. undefined.
1996;85(11):1142–69.
30.
Ain S, Ain Q, Parveen S. an Overview on Various
Approaches Used for Solubilization of Poorly Soluble Drugs. T Pharm Res.
2009;(2):84–104.
31.
Marques HMC. A review on cyclodextrin encapsulation
of essential oils and volatiles. Flavour Fragr J. 2010 Sep;25(5):313–26.
32.
Astray G, Gonzalez-Barreiro C, Mejuto JC,
Rial-Otero R, Simal-Gándara J. A review on the use of cyclodextrins in foods.
Food Hydrocoll. 2009 Oct;23(7):1631–40.
33.
Del Valle EMM. Cyclodextrins and their uses: a
review. Process Biochem. 2004 May;39(9):1033–46.
34.
Loftsson, T. and Brewster, M.E. (1996)
Pharmaceutical Applications of Cycldextrins. 1. Drug Solubilization and
Stabilization. Journal of Pharamceutical Science, 85, 10171025. - References -
Scientific Research Publishing.
35.
Gabelica V, Galic N, De Pauw E. On the specificity
of cyclodextrin complexes detected by electrospray mass spectrometry. J Am Soc
Mass Spectrom. 2002 Aug;13(8):946–53.
36.
Loftsson T, Brewster ME, Másson M. Role of
cyclodextrins in improving oral drug delivery. Am J Drug Deliv.
2004;2(4):261–75.
37.
Loftsson T, Magnúsdóttir A, Másson M,
Sigurjónsdóttir JF. Self-association and cyclodextrin solubilization of drugs.
J Pharm Sci. 2002 Nov;91(11):2307–16.
38.
Loftsson T, Duchˆ D. Cyclodextrins and their
pharmaceutical applications. 2007;329:1–11.
39.
Loftsson T, Brewster ME. Pharmaceutical
Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization. J
Pharm Sci. 1996 Oct;85(10):1017–25.
40.
Suvarna V, Gujar P, Murahari M. ScienceDirect
Complexation of phytochemicals with cyclodextrin derivatives – An insight.
Biomed Pharmacother [Internet]. 2017;88:1122–
44. Available from:
http://dx.doi.org/10.1016/j.biopha.2017.01.157
41.
Stella VJ, Rajewski RA. Cyclodextrins: their future
in drug formulation and delivery. Pharm Res. 1997;14(5):556–67.
42.
Kwon Y, Kim H, Park S, Jung S. Enhancement of
Solubility and Antioxidant Activity of Some Flavonoids Based on the Inclusion
Complexation with Sulfobutylether β Cyclodextrin. 2010;31(10):3035–7.
43.
Carneiro SB, Duarte FÍC, Heimfarth L, Quintans
JDSS, Quintans-Júnior LJ, Júnior VFDV, et al. Cyclodextrin–Drug Inclusion
Complexes: In Vivo and In Vitro Approaches. Int J Mol Sci 2019, Vol 20, Page
642. 2019 Feb;20(3):642.
44.
Pinho E, Grootveld M, Soares G, Henriques M.
Cyclodextrins as encapsulation agents for plant bioactive compounds. Carbohydr
Polym. 2014;101(1):121–35.
45.
Duarte A, Martinho A, Luís Â, Figueiras A, Oleastro
M, Domingues FC, et al. Resveratrol encapsulation with methyl-β-cyclodextrin
for antibacterial and antioxidant delivery applications. LWT - Food Sci
Technol. 2015 Oct;63(2):1254–60.
46.
D’Aria F, Serri C, Niccoli M, Mayol L,
Quagliariello V, Iaffaioli RV, et al. Host–guest inclusion complex of quercetin
and hydroxypropyl-β-cyclodextrin. J Therm Anal Calorim 2017 1301. 2017
Feb;130(1):451–6.
47.
Wei Y, Zhang J, Memon AH, Liang H. Molecular model
and in vitro antioxidant activity of a water-soluble and stable
phloretin/hydroxypropyl-β-cyclodextrin inclusion complex. J Mol Liq. 2017
Jun;236:68–75.
48.
Dahabra L, Broadberry G, Gresley A Le, Najlah M.
Sunscreens Containing Cyclodextrin Inclusion Complexes for Enhanced
Efficiency : A Strategy for Skin Cancer Prevention. 2021;1–22.
49.
Viernstein H, Weiss-greiler P, Wolschann P.
Solubility enhancement of low soluble biologically active compounds —
temperature and cosolvent dependent inclusion complexation.
2003;256:85–94.
50.
Varandal AB, Magar DD, Saudagar RB. Different
approaches toward the enhancement of Drug Solubility: A Review. J Adv Pharm
Educ Res. 2013;3(4):415–26.
51.
Carvalho YMBG, Menezes PP, Sousa BMH, Lima BS,
Trindade IAS, Serafini MR, et al. Inclusion complex between β-cyclodextrin and
hecogenin acetate produces superior analgesic effect in animal models for
orofacial pain. Biomed Pharmacother. 2017;93:754–62.
52.
Patil JS, Kadam D V., Marapur SC, Kamalapur M V.
Inclusion complex system; a novel technique to improve the solubility and
bioavailability of poorly soluble drugs: A review. Int J Pharm Sci Rev Res.
2010;2(2):29–34.
53.
Ain S, Gupta V, K B, Ain Q, Dahiya J. Solubility
Enhancement of the Poorly WaterSoluble Antiulcer Drug Famotidine by Inclusion
Complexation. Int J Pharm Sci Nanotechnol. 2013 May;6(1):1983–9.
54.
Banjare MK, Banjare RK, Behera K, Pandey S, Mundeja
P, Ghosh KK. Inclusion complexation of novel synthesis amino acid based ionic
liquids with β-cyclodextrin. J Mol Liq. 2020;299:112204.
55.
Arima H, Yunomae K, Miyake K, Irie T, Hirayama F,
Uekama K. Comparative studies of the enhancing effects of cyclodextrins on the
solubility and oral bioavailability of tacrolimus in rats. J Pharm Sci.
2001;90(6):690–701.
56.
Veiga F, Fernandes C, Teixeira F. Oral
bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin
inclusion complexes. Int J Pharm. 2000 Jul;202(1–2):165–71.
57.
Miyake K, Arima H, Hirayama F, Yamamoto M, Horikawa
T, Sumiyoshi H, et al. Improvement of solubility and oral bioavailability of
rutin by complexation with 2hydroxypropyl-β-cyclodextrin. Pharm Dev Technol.
2000;5(3):399–407.
58.
Loftsson T, Brewster ME. Cyclodextrins as
Functional Excipients : Methods to Enhance Complexation Efficiency.
2012;101(9):10–2.
59.
Cid-samamed A, Rakmai J, Carlos J, Simal-gandara J,
Astray G. Cyclodextrins inclusion complex : Preparation methods , analytical
techniques and food industry applications. Food Chem [Internet].
2022;384(August 2021):132467. Available from:
https://doi.org/10.1016/j.foodchem.2022.132467
60.
Fernandes CM, Veiga FJB. Effect of the hydrophobic
nature of triacetyl-betacyclodextrin on the complexation with nicardipine
hydrochloride: physicochemical and dissolution properties of the kneaded and
spray-dried complexes. Chem Pharm Bull (Tokyo). 2002 Dec;50(12):1597–602.
61.
Cunha-Filho MSS, Dacunha-Marinho B,
Torres-Labandeira JJ, Martínez-Pancheco R, Landín M. Characterization of
beta-lapachone and methylated beta-cyclodextrin solidstate systems. AAPS
PharmSciTech. 2007 Jul;8(3).
62.
Patel R, Bhimani D, Patel J, Patel D. Solid-state
characterization and dissolution properties of ezetimibe-cyclodextrins inclusion
complexes. J Incl Phenom Macrocycl Chem. 2008;60(3–4):241–51.
63.
Kiran T, Shastri N, Ramakrishna S, Sadanandam M.
surface solid dispersion of glimepiride for enhancement of dissolution rate.
2009;
64.
Sheetal Z Godse MS, Patil, Swapnil M Kothavade RBS.
Techniques for solubility enhancement of Hydrophobic drugs : A Review. J Adv
Pharm Educ Res. 2013;3(4):403–14.
65.
Cao F, Guo J, Ping Q. The physicochemical
characteristics of freeze-dried scutellarincyclodextrin tetracomponent
complexes. Drug Dev Ind Pharm. 2005;31(8):747–56.
66.
Patel VR, Agrawal Y. Nanosuspension: An approach to
enhance solubility of drugs. J Adv Pharm Technol Res. 2011;2(2):81.
67.
Celebioglu A, Uyar T, Uyar T. Development of
Ferulic Acid / Cyclodextrin Inclusion Complex Nanofibers for Fast-Dissolving
Drug Delivery System. 2020;
68.
Anjum MM, Patel KK, Pandey N, Tilak R, Agrawal AK,
Singh S. Development of Anacardic Acid/hydroxypropyl-β-cyclodextrin inclusion
complex with enhanced solubility and antimicrobial activity. J Mol Liq.
2019;296(xxxx).
69.
Goyal G, Phukan AC, Hussain M, Lal V, Modi M, Goyal
MK, et al. Water-soluble complexes of orange pigments from Monascus sp. with
HP-β-CD: Preparation, inclusion mechanism, and improved stability, Jo ur na l
P. J Neurol Sci. 2019;116544.
70.
Uyar* AC and T. Development of Ferulic
Acid/Cyclodextrin Inclusion Complex Nanofibers for Fast-Dissolving Drug
Delivery System. Int J Pharm. 2020.
71.
Frangou M, Vlugt TJH, Moultos OA, Erd M. β
-cyclodextrin : Ibuprofen in aqueous solutions ; A molecular dynamics simulation
study. 2021;528.
72.
Celebioglu A, Uyar T. Fast-dissolving antioxidant
curcumin / cyclodextrin inclusion complex electrospun nano fi brous webs.
2020;317(February).
73.
Loh GOK, Tan YTF, Peh KK. Enhancement of
norfloxacin solubility via inclusion complexation with β-cyclodextrin and its
derivative hydroxypropyl-β-cyclodextrin.
Asian J Pharm Sci. 2016;11(4):536–46.
74.
Gao S, Jiang J, Li X, Ye F, Fu Y, Zhao L. An
environmentally safe formulation with enhanced solubility and fungicidal
activity : Self-assembly and characterization of Difenoconazole- β -CD
inclusion complex. 2021;327.
75.
Mohandoss S, Palanisamy S, You SG, Shim JJ, Rok Lee
Y. Ultrasonication-assisted host–guest inclusion complexes of β-cyclodextrins
and 5-hydroxytryptophan: Enhancement of water solubility, thermal stability,
and in vitro anticancer activity. J Mol Liq. 2021;336.